Biological Profiling of Anti-HIV Agents and Insight into CCR5 Antagonist Binding Using in silico Techniques - Inria - Institut national de recherche en sciences et technologies du numérique Accéder directement au contenu
Article Dans Une Revue ChemMedChem Année : 2009

Biological Profiling of Anti-HIV Agents and Insight into CCR5 Antagonist Binding Using in silico Techniques

Antonio Carrieri
  • Fonction : Auteur correspondant
  • PersonId : 864872

Connectez-vous pour contacter l'auteur
Violeta I. Pérez-Nueno
  • Fonction : Auteur
Alessandra Fano
  • Fonction : Auteur
Carlo Pistone
  • Fonction : Auteur
David Ritchie
Jordi Teixidó
  • Fonction : Auteur

Résumé

Molecular requirements and determinants for efficient binding to CCR5 were interpreted by computational techniques based on comparative receptor structure modeling, advanced 3D-QSAR, docking, and shape-based virtual screening of commercially available entry blockers. Results of this study may be valuable for predicting new HIV entry-blocking leads. Acquired immune deficiency syndrome (AIDS) is responsible for more than 31 million deaths, and many more people are affected by this disease worldwide. Novel ligands that are capable of blocking virus-cell fusion are emerging as promising candidate molecules against HIV-1 infection because they have the promise to overcome the major drawbacks of classical highly active antiretroviral (HAART) drugs. However, structure-based design continues to be hampered owing to the paucity of experimentally determined 3D information about HIV-1 cell-surface co-receptors. Using computational techniques based on comparative receptor structure modeling, advanced 3D-QSAR, and protein-ligand docking, we present recent results that define updated molecular requirements and determinants for efficient binding of small-molecule ligands to CCR5, a principal biological target for HIV entry blockers. These results are compared with shape- and property-based virtual screening results for commercially available entry blockers, and will be valuable for predicting new HIV entry-blocking leads.

Dates et versions

inria-00434260 , version 1 (21-11-2009)

Identifiants

Citer

Antonio Carrieri, Violeta I. Pérez-Nueno, Alessandra Fano, Carlo Pistone, David Ritchie, et al.. Biological Profiling of Anti-HIV Agents and Insight into CCR5 Antagonist Binding Using in silico Techniques. ChemMedChem, 2009, 4 (7), pp.1153-1163. ⟨10.1002/cmdc.200900101⟩. ⟨inria-00434260⟩
202 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More